home / stock / optn / optn quote
Last: | $1.045 |
---|---|
Change Percent: | -0.95% |
Open: | $1.06 |
Close: | $1.045 |
High: | $1.06 |
Low: | $1.04 |
Volume: | 289,122 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.045 | $1.06 | $1.045 | $1.06 | $1.04 | 289,122 | 07-05-2024 |
$1.05 | $1.06 | $1.05 | $1.07 | $1.03 | 249,256 | 07-04-2024 |
$1.05 | $1.06 | $1.05 | $1.07 | $1.03 | 249,256 | 07-03-2024 |
$1.04 | $1.05 | $1.04 | $1.05 | $1.02 | 569,511 | 07-02-2024 |
$1.05 | $1.04 | $1.05 | $1.08 | $1.03 | 1,209,212 | 07-01-2024 |
$1.04 | $1.08 | $1.04 | $1.125 | $1.03 | 9,441,328 | 06-28-2024 |
$1.08 | $1.03 | $1.08 | $1.1 | $1.015 | 1,354,989 | 06-27-2024 |
$0.998 | $1.01 | $0.998 | $1.15 | $0.99 | 1,066,034 | 06-26-2024 |
$1.03 | $1.08 | $1.03 | $1.09 | $1.03 | 986,199 | 06-25-2024 |
$1.07 | $1.08 | $1.07 | $1.13 | $1.06 | 1,003,972 | 06-24-2024 |
$1.09 | $1.12 | $1.09 | $1.18 | $1.09 | 2,010,446 | 06-21-2024 |
$1.13 | $1.14 | $1.13 | $1.2 | $1.12 | 842,253 | 06-20-2024 |
$1.15 | $1.18 | $1.15 | $1.19 | $1.12 | 545,296 | 06-19-2024 |
$1.15 | $1.18 | $1.15 | $1.19 | $1.12 | 545,296 | 06-18-2024 |
$1.19 | $1.18 | $1.19 | $1.22 | $1.14 | 328,066 | 06-17-2024 |
$1.155 | $1.18 | $1.155 | $1.2 | $1.13 | 281,898 | 06-14-2024 |
$1.19 | $1.22 | $1.19 | $1.24 | $1.13 | 390,663 | 06-13-2024 |
$1.24 | $1.26 | $1.24 | $1.335 | $1.2 | 551,202 | 06-12-2024 |
$1.26 | $1.15 | $1.26 | $1.28 | $1.13 | 510,169 | 06-11-2024 |
$1.17 | $1.07 | $1.17 | $1.21 | $1.04 | 551,773 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
YARDLEY, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that XHANCE ® (fluticasone propionate) has been added to Express Scripts’ nationa...
YARDLEY, Pa., May 17, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the H.C...
2024-05-15 10:30:03 ET Lake Street analyst issues BUY recommendation for OPTN on May 15, 2024 08:43AM ET. The previous analyst recommendation was Buy. OPTN was trading at $1.13 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analy...